NCT05119335 2025-11-12
A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma
NiKang Therapeutics, Inc.
Phase 1/2 Terminated
NiKang Therapeutics, Inc.
Rain Oncology Inc
Rain Oncology Inc
BioMed Valley Discoveries, Inc